Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Changes of visual functions in patients with pituitary adenoma.

Kasputytė R, Slatkevičienė G, Liutkevičienė R, Glebauskienė B, Bernotas G, Tamašauskas A.

Medicina (Kaunas). 2013;49(3):132-7.

2.

The Application of a New Maximum Color Contrast Sensitivity Test to the Early Prediction of Chiasma Damage in Cases of Pituitary Adenoma: The Pilot Study.

Slatkeviciene G, Liutkeviciene R, Glebauskiene B, Zaliuniene D, Kriauciuniene L, Bernotas G, Tamasauskas A.

Korean J Ophthalmol. 2016 Aug;30(4):295-301. doi: 10.3341/kjo.2016.30.4.295. Epub 2016 Jul 21.

3.

Vision-related quality of life in patients with pituitary adenoma.

Okamoto Y, Okamoto F, Hiraoka T, Yamada S, Oshika T.

Am J Ophthalmol. 2008 Aug;146(2):318-322. doi: 10.1016/j.ajo.2008.04.018. Epub 2008 Jun 6.

PMID:
18538298
4.

Intraoperative magnetic resonance imaging and early prognosis for vision after transsphenoidal surgery for sellar lesions.

Berkmann S, Fandino J, Zosso S, Killer HE, Remonda L, Landolt H.

J Neurosurg. 2011 Sep;115(3):518-27. doi: 10.3171/2011.4.JNS101568. Epub 2011 Jun 3.

PMID:
21639700
5.

Vision-related quality of life after transsphenoidal surgery for pituitary adenoma.

Okamoto Y, Okamoto F, Yamada S, Honda M, Hiraoka T, Oshika T.

Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3405-10. doi: 10.1167/iovs.09-3763. Epub 2010 Feb 24.

PMID:
20181847
6.

Visual parameters in patients with pituitary adenoma before and after transsphenoidal surgery.

Marcus M, Vitale S, Calvert PC, Miller NR.

Aust N Z J Ophthalmol. 1991 May;19(2):111-8.

PMID:
1930993
7.

Farnsworth-Munsell 100-hue test for patients with diabetes mellitus.

Utku D, Atmaca LS.

Ann Ophthalmol. 1992 Jun;24(6):205-8.

PMID:
1444079
8.

Predicting impairment of central vision from dimensions of the optic chiasm in patients with pituitary adenoma.

Carrim ZI, Reeks GA, Chohan AW, Dunn LT, Hadley DM.

Acta Neurochir (Wien). 2007 Mar;149(3):255-60; discussion 260. Epub 2007 Feb 2.

PMID:
17273885
9.

Color axis evaluation of the Farnsworth Munsell 100-hue test in primary open-angle glaucoma and normal-pressure glaucoma.

Budde WM, Jünemann A, Korth M.

Graefes Arch Clin Exp Ophthalmol. 1996 Aug;234 Suppl 1:S180-6.

PMID:
8871171
10.

[The clinical study of the damage of visual function caused by pituitary tumor].

Qi C, Li Q, Wang D, Dong L, Yang J, Li Q, Chen M.

Yan Ke Xue Bao. 2008 Mar;24(1):62-4. Chinese.

PMID:
18709961
11.

Losses of hemifield contrast sensitivity in patients with pituitary adenoma and normal visual acuity and visual field.

Porciatti V, Ciavarella P, Ghiggi MR, D'Angelo V, Padovano S, Grifa M, Moretti G.

Clin Neurophysiol. 1999 May;110(5):876-86.

PMID:
10400201
12.

[Associations between color perception and optic nerve disk drusen].

Liutkevičienė R, Zaliūnienė D, Stanislovaitienė D, Jašinskas V.

Medicina (Kaunas). 2010;46(12):821-6. Lithuanian.

13.

Humphrey visual field analysis, visual field defects, and ophthalmic findings in patients with macro pituitary adenoma.

Gedik S, Gur S, Atalay B, Colak M, Altinors N, Akova YA.

Saudi Med J. 2007 Sep;28(9):1380-4.

PMID:
17768464
14.

[Visual field defects in 169 cases of pituitary adenomas].

Shen MQ, Ye W, Zhang YY, Chen J.

Zhonghua Yan Ke Za Zhi. 2009 Dec;45(12):1074-9. Chinese.

PMID:
20193428
15.

Contrast sensitivity and other vision tests in the optic neuritis treatment trial.

Trobe JD, Beck RW, Moke PS, Cleary PA.

Am J Ophthalmol. 1996 May;121(5):547-53.

PMID:
8610798
16.

A new maximum color contrast sensitivity test for detecting early changes of visual function in age-related macular degeneration.

Liutkevičienė R, Cebatorienė D, Zaliūnienė D, Lukauskienė R, Jašinskas V.

Medicina (Kaunas). 2014;50(5):281-6. doi: 10.1016/j.medici.2014.10.008. Epub 2014 Nov 1.

17.

Patterns of visual loss associated with pituitary macroadenomas.

Poon A, McNeill P, Harper A, O'Day J.

Aust N Z J Ophthalmol. 1995 May;23(2):107-15.

PMID:
7546685
18.

Clinical and genetic analysis of a family affected with dominant optic atrophy (OPA1)

Brown J Jr, Fingert JH, Taylor CM, Lake M, Sheffield VC, Stone EM.

Arch Ophthalmol. 1997 Jan;115(1):95-9. Erratum in: Arch Ophthalmol 1997 May;115(5):663.

PMID:
9006432
19.

Macular function impairment in eyes with early age-related macular degeneration.

Midena E, Degli Angeli C, Blarzino MC, Valenti M, Segato T.

Invest Ophthalmol Vis Sci. 1997 Feb;38(2):469-77.

PMID:
9040480
20.

[Surgical treatment for giant pituitary adenomas: the state of visual functions].

Kadashev BA, Faĭzullaev RB, Kalinin PL, Kutin MA, Shkarubo AN, Alekseev SN, Fomichev DV, Grigor'eva NN, Tropinskaia OF.

Vestn Oftalmol. 2009 Mar-Apr;125(2):7-10. Russian.

PMID:
19517822

Supplemental Content

Support Center